This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Missouri. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Dennis B Lubahn: Innovator in Obesity Treatment
Introduction
Dennis B Lubahn is a notable inventor based in Columbia, MO (US). He has made significant contributions to the field of obesity treatment through his innovative research and patent.
Latest Patents
Lubahn holds a patent for a drug combination aimed at treating obesity, pre-diabetes, diabetes, and obese breast cancer. The patent describes methods that increase mitochondrial metabolism by enhancing the activity of uncoupling protein 1 (UCP1) in adipocytes. The methods involve contacting an adrenergic receptor agonist with an adipocyte where the genomic activity of estrogen receptor beta (ERβ) has been inhibited or inactivated. This innovative approach provides a potential pathway for more effective treatments in managing obesity and related conditions.
Career Highlights
Lubahn is affiliated with the University of Missouri, where he continues to advance research in metabolic health. His work has garnered attention for its potential impact on obesity treatment and related metabolic disorders.
Collaborations
Some of his notable coworkers include Eric D Queathem and Victoria J Vieira-Potter. Their collaborative efforts contribute to the ongoing research and development in the field of obesity treatment.
Conclusion
Dennis B Lubahn's innovative work in obesity treatment exemplifies the importance of research and patents in advancing medical science. His contributions are paving the way for new therapeutic strategies in combating obesity and its associated health issues.